[Effect of methotrexate-citrovorum factor (MTX-CF) rescue therapy in a case of malignant histiocytosis with disseminated intravascular coagulation (author's transl)]. 1981

S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino

UI MeSH Term Description Entries
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
January 1979, Zhonghua zhong liu za zhi [Chinese journal of oncology],
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
October 1979, Nihon Gan Chiryo Gakkai shi,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
May 1981, La Clinica terapeutica,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
March 1981, Klinische Padiatrie,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
August 1980, Wiener klinische Wochenschrift,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
October 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
April 1981, No shinkei geka. Neurological surgery,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
January 1978, Przeglad lekarski,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
June 1975, The New England journal of medicine,
S Fukuhara, and R Kim, and Y Aoki, and S Okada, and M Yoneda, and K Kita, and K Nasu, and E Tatsumi, and S Shirakawa, and H Uchino
October 1977, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!